LEO Pharma has submitted an NDA in China for Enstilar, a new treatment for plaque psoriasis. Enstilar aims to improve upon the existing standard treatment, Daivobet ointment.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
LEO Pharma has submitted an NDA in China for Enstilar, a new treatment for plaque psoriasis. Enstilar aims to improve upon the existing standard treatment, Daivobet ointment.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.